Research VaultRetatrutide
Ordered Retatrutide from Research Vault? Mail in a sample (US only) and let us test it.
Test my supplyResearch Vault's Retatrutide evidence is clean but still sparse, so the smoothed rating is driven by limited recent lab support rather than failures. Note purity rose from 99.6% to 100%, while the latest vial overfilled by 19%.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Research Vault rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 2 Nov 2026 | Pass | 45rxs2b Tested | lab name | View COA | |||
| 6 Aug 2026 | Pass | d93r8yw Tested | lab name | View COA | |||
About Research Vault test results from Finnrick
Research Vault is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 2 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Research Vault peptides in this dataset are Tirzepatide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 2 recent tests.
Ordered Retatrutide from Research Vault? Mail in a sample (US only) and let us test it.
Test my supply